Hunter Perkins Capital Management, LLC Tarsus Pharmaceuticals, Inc. Transaction History

Hunter Perkins Capital Management, LLC

  • $488 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$21.45 - $29.22 $166,881 - $227,331
-7,780 Closed
0 $0
Q1 2021

Apr 28, 2021
SELL
$27.37 - $47.25 $6,021 - $10,395
-220 Reduced 2.75%
7,780 $251,000
Q4 2020

Feb 03, 2021
BUY
$19.17 - $49.62 $153,360 - $396,960
8,000 New
8,000 $331,000

Others Institutions Holding TARS

# of Institutions
166
Shares Held
39.5M
Call Options Held
190K
Put Options Held
92.9K
View Full List

About Tarsus Pharmaceuticals, Inc.

TARS Quotes by TradingView
  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $743M
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Hunter Perkins Capital Management, LLC Portfolio

Follow Hunter Perkins Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunter Perkins Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunter Perkins Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email